D-0851-2021 Class II Terminated
FDA drug recall D-0851-2021 was initiated by Viatris on August 23, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated September 7, 2022). Affected quantity: 9,515 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- October 6, 2021
- Initiation Date
- August 23, 2021
- Termination Date
- September 7, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,515 bottles
Product Description
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Reason for Recall
Failed Dissolution Specifications
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022